Sun Pharma up 2% as arm gets relief by US court in patent infringement case

On a year-to-date (YTD) basis, Sun Pharma stock has underperformed the Nifty Pharma index by declining around 28 per cent.

from Latest News http://bit.ly/2AgmUME
https://ift.tt/eA8V8J http://bit.ly/2SdCH5P

• Tweet
• Share
• Share
• Share
• Share